Global Primary Hepatocytes Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Primary Hepatocytes Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Primary Hepatocytes report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Primary Hepatocytes market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Demand from Life Science Research Companies and Research Institutes are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Primary Hepatocytes industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, Primary Hepatocytes key manufacturers include Thermo Fisher Scientific, Inc., Merck KGaA, Lonza, Cell Biologics, Inc., PromoCell GmbH, HemaCare Corporation, ZenBio, Inc., STEMCELL Technologies, Inc. and Corning Incorporated, etc. Thermo Fisher Scientific, Inc., Merck KGaA, Lonza are top 3 players and held % sales share in total in 2022.
Primary Hepatocytes can be divided into Human Primary Cells and Animal Primary Cells, etc. Human Primary Cells is the mainstream product in the market, accounting for % sales share globally in 2022.
Primary Hepatocytes is widely used in various fields, such as Life Science Research Companies, Research Institutes and Others,, etc. Life Science Research Companies provides greatest supports to the Primary Hepatocytes industry development. In 2022, global % sales of Primary Hepatocytes went into Life Science Research Companies filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Primary Hepatocytes market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Thermo Fisher Scientific, Inc.
Merck KGaA
Lonza
Cell Biologics, Inc.
PromoCell GmbH
HemaCare Corporation
ZenBio, Inc.
STEMCELL Technologies, Inc.
Corning Incorporated
AllCells
Axol Bioscience Ltd.
iXCells Biotechnologies
Neuromics
StemExpress
BioIVT
ScienCell Research Laboratories, Inc.
PPA Research Group, Inc.
Creative Bioarray
BPS Bioscience, Inc.
Epithelix Sàrl
ReachBio LLC
AcceGen
Sekisui XenoTech, LLC
Biopredic International
Segment by Type
Human Primary Cells
Animal Primary Cells
Life Science Research Companies
Research Institutes
Others
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Primary Hepatocytes market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Primary Hepatocytes, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Primary Hepatocytes industry.
Chapter 3Historical (2018-2022) and forecast (2023-2033) volume and revenue analysis of Primary Hepatocytes in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Primary Hepatocytes introduction, etc. Primary Hepatocytes Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13MRAResearch’s Conclusions of Primary Hepatocytes market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by MRAResearch.
North America, Europe and Asia Pacific are the key regions for Primary Hepatocytes industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, Primary Hepatocytes key manufacturers include Thermo Fisher Scientific, Inc., Merck KGaA, Lonza, Cell Biologics, Inc., PromoCell GmbH, HemaCare Corporation, ZenBio, Inc., STEMCELL Technologies, Inc. and Corning Incorporated, etc. Thermo Fisher Scientific, Inc., Merck KGaA, Lonza are top 3 players and held % sales share in total in 2022.
Primary Hepatocytes can be divided into Human Primary Cells and Animal Primary Cells, etc. Human Primary Cells is the mainstream product in the market, accounting for % sales share globally in 2022.
Primary Hepatocytes is widely used in various fields, such as Life Science Research Companies, Research Institutes and Others,, etc. Life Science Research Companies provides greatest supports to the Primary Hepatocytes industry development. In 2022, global % sales of Primary Hepatocytes went into Life Science Research Companies filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Primary Hepatocytes market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Thermo Fisher Scientific, Inc.
Merck KGaA
Lonza
Cell Biologics, Inc.
PromoCell GmbH
HemaCare Corporation
ZenBio, Inc.
STEMCELL Technologies, Inc.
Corning Incorporated
AllCells
Axol Bioscience Ltd.
iXCells Biotechnologies
Neuromics
StemExpress
BioIVT
ScienCell Research Laboratories, Inc.
PPA Research Group, Inc.
Creative Bioarray
BPS Bioscience, Inc.
Epithelix Sàrl
ReachBio LLC
AcceGen
Sekisui XenoTech, LLC
Biopredic International
Segment by Type
Human Primary Cells
Animal Primary Cells
Segment by Application
Life Science Research Companies
Research Institutes
Others
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Primary Hepatocytes market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Primary Hepatocytes, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Primary Hepatocytes industry.
Chapter 3Historical (2018-2022) and forecast (2023-2033) volume and revenue analysis of Primary Hepatocytes in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Primary Hepatocytes introduction, etc. Primary Hepatocytes Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13MRAResearch’s Conclusions of Primary Hepatocytes market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by MRAResearch.